Efficacy of a retinoid complex plus anti-inflammatory component cream alone or in combination with prebiotic food supplement in adult acne: A randomized, assessor-blinded, parallel-group, multicenter trial on 184 women.
adult female acne
iris Florentina root extract
prebiotic
treatment regimens
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
03
05
2022
received:
19
03
2022
accepted:
05
05
2022
pubmed:
13
5
2022
medline:
28
12
2022
entrez:
12
5
2022
Statut:
ppublish
Résumé
Adult female acne (AFA) nowadays is a very common skin condition affecting mainly women aged between 25 and 40. The treatment of AFA could be challenging. We evaluate and compare the efficacy and tolerability of a cream formulation containing two retinoid molecules (hydroxypinacolone/retinyl palmitate) combined with Iris Florentina root extract and a complex of three oligopeptides (C) applied twice a day (morning and evening) alone or in combination (C + O) with a food supplement containing a mixture of prebiotic molecules (FOS&GOS) zinc, lactoferrin, and niacinamide. In a multicenter, randomized, assessor-blinded, 12-week trial, we assessed the efficacy of these two regimens in the evolution of AFA lesions (non-inflammatory: NI-L; inflammatory: IL; and total number of lesions: TL). Additional efficacy endpoints were the evolution of the 6-point (from 0 to 5) GEA and Adult Female Acne Scoring Tool (AFAST) scores. One hundred and eighty-four women (mean age 32 ± 6 years) with AFA agreed to participate after obtaining informed consent. They were randomized (2:1) to the topical product (n = 123) (Group C) or to the combination (n = 61) (Group C + O) treatment. All enrolled patients concluded the trial with no drop-out. At baseline, NI-L, IL, and TL acne lesion count were 15 ± 9, 9 ± 5, and 24 ± 14 in the Group C and 19 ± 8, 9 ± 4, and 29 ± 10 in Group C + O. In comparison with the number of the acne lesions at the baseline, both treatment regimens induced a significant reduction (p = 0.0001, ANOVA test) at Week 12 in NI-L, IL, and TL by -54%, -63%, and - 59% in Group C and by -55%, -73%, and - 61% in the Group C + O, respectively. At Week 12, the absolute IL count reduction vs. baseline was significantly (p = 0.0158) greater in Group C + O (-7.0) in comparison with Group C (-5.5). The GEA absolute score reduction in Group C + O group was significantly greater in comparison with Group C (-1.5 vs. -1.1; p = 0.0097). In the Group C + O, a greater percentage of success treatment (defined as a GEA score of 0/1 at Week 12) was observed in comparison with Group C (39% vs. 27%; p = 0.06). AFAST score at baseline was 2.4 ± 0.5 in group C and 2.8 ± 0.6 in group C + O. AFAST score was reduced by 21% and by 51% after 6 and 12 weeks of treatment in group C and by 22% and 55% in group C + O, respectively. Both treatment regimens were well tolerated. Not relevant adverse events were recorded. A cream containing retinoid molecules and Iris Florentina root extract is effective and well tolerated in the management of AFA. The treatment combination with a prebiotic and anti-inflammatory food supplement offers an additional clinical benefit mainly in reducing inflammatory lesions and improving the severity acne score.
Sections du résumé
BACKGROUND
BACKGROUND
Adult female acne (AFA) nowadays is a very common skin condition affecting mainly women aged between 25 and 40. The treatment of AFA could be challenging.
STUDY AIM
OBJECTIVE
We evaluate and compare the efficacy and tolerability of a cream formulation containing two retinoid molecules (hydroxypinacolone/retinyl palmitate) combined with Iris Florentina root extract and a complex of three oligopeptides (C) applied twice a day (morning and evening) alone or in combination (C + O) with a food supplement containing a mixture of prebiotic molecules (FOS&GOS) zinc, lactoferrin, and niacinamide.
SUBJECTS AND METHODS
METHODS
In a multicenter, randomized, assessor-blinded, 12-week trial, we assessed the efficacy of these two regimens in the evolution of AFA lesions (non-inflammatory: NI-L; inflammatory: IL; and total number of lesions: TL). Additional efficacy endpoints were the evolution of the 6-point (from 0 to 5) GEA and Adult Female Acne Scoring Tool (AFAST) scores.
RESULTS
RESULTS
One hundred and eighty-four women (mean age 32 ± 6 years) with AFA agreed to participate after obtaining informed consent. They were randomized (2:1) to the topical product (n = 123) (Group C) or to the combination (n = 61) (Group C + O) treatment. All enrolled patients concluded the trial with no drop-out. At baseline, NI-L, IL, and TL acne lesion count were 15 ± 9, 9 ± 5, and 24 ± 14 in the Group C and 19 ± 8, 9 ± 4, and 29 ± 10 in Group C + O. In comparison with the number of the acne lesions at the baseline, both treatment regimens induced a significant reduction (p = 0.0001, ANOVA test) at Week 12 in NI-L, IL, and TL by -54%, -63%, and - 59% in Group C and by -55%, -73%, and - 61% in the Group C + O, respectively. At Week 12, the absolute IL count reduction vs. baseline was significantly (p = 0.0158) greater in Group C + O (-7.0) in comparison with Group C (-5.5). The GEA absolute score reduction in Group C + O group was significantly greater in comparison with Group C (-1.5 vs. -1.1; p = 0.0097). In the Group C + O, a greater percentage of success treatment (defined as a GEA score of 0/1 at Week 12) was observed in comparison with Group C (39% vs. 27%; p = 0.06). AFAST score at baseline was 2.4 ± 0.5 in group C and 2.8 ± 0.6 in group C + O. AFAST score was reduced by 21% and by 51% after 6 and 12 weeks of treatment in group C and by 22% and 55% in group C + O, respectively. Both treatment regimens were well tolerated. Not relevant adverse events were recorded.
CONCLUSION
CONCLUSIONS
A cream containing retinoid molecules and Iris Florentina root extract is effective and well tolerated in the management of AFA. The treatment combination with a prebiotic and anti-inflammatory food supplement offers an additional clinical benefit mainly in reducing inflammatory lesions and improving the severity acne score.
Substances chimiques
Retinoids
0
Anti-Inflammatory Agents
0
Emollients
0
Types de publication
Randomized Controlled Trial
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5716-5722Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361-372.
Chlebus E, Chlebus M. Factors affecting the course and severity of adult acne. Observational cohort study. J Dermatol Treat. 2017;28(8):737-744.
Dréno B, Layton A, Zouboulis CC, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol. 2013;27(9):1063-1070.
Bagatin E, Freitas THPD, Rivitti-Machado MC, Ribeiro BM, Nunes S, Rocha MADD. Adult female acne: a guide to clinical practice. An Bras Dermatol. 2019;94:62-75.
Capitanio B, Sinagra JL, Ottaviani M, Bordignon V, Amantea A, Picardo M. Acne and smoking. Dermato-Endocrinology. 2009;1(3):129-135.
Wolkenstein P, Misery L, Amici JM, et al. Smoking and dietary factors associated with moderate-to-severe acne in French adolescents and young adults: results of a survey using a representative sample. Dermatology. 2015;230(1):34-39.
Zeichner JA, Baldwin HE, Cook-Bolden FE, Eichenfield LF, Friedlander SF, Rodriguez DA. Emerging issues in adult female acne. J Clin Aesthet Dermatol. 2017;10(1):37-46.
Prakash C, Bhargava P, Tiwari S, Majumdar B, Bhargava RK. Skin surface pH in acne vulgaris: insights from an observational study and review of the literature. J Clin Aesthet Dermatol. 2017;10(7):33-39.
Dréno B. Treatment of adult female acne: a new challenge. J Eur Acad Dermatol Venereol. 2015;29:14-19.
Dall'Oglio F, Milani M, Micali G. Effects of oral supplementation with FOS and GOS prebiotics in women with adult acne: the “SO sweet” study: a proof-of-concept pilot trial. Clin Cosmet Investig Dermatol. 2018;11:445-449.
Notay M, Foolad N, Vaughn AR, Sivamani RK. Probiotics, prebiotics, and synbiotics for the treatment and prevention of adult dermatological diseases. Am J Clin Dermatol. 2017;18(6):721-732.
Crişan I, Cantor M. New perspectives on medicinal properties and uses of iris sp. Hop Med Plants. 2016;24:24-36.
Fujita M, INOUE T. Studies on the constituents of Iris florentina L. II. C-glucosides of xanthones and flavones from the leaves. Chem Pharm Bull. 1982;30(7):2342-2348.
Veraldi S, Barbareschi M, Alessandrini G, et al. Evaluation of a combination of retinol, hydroxyl-pinacolone retinoate (Retinsphere), an antibacterial agent (BIOPEP. 15), salicylic acid and vitamin E in subjects suffering from predominant comedonal acne-an Italian multicenter prospective open study. J Dermatolog Clin Res. 2016;4(3):1072.
Villani A, Annunziata MC, Cinelli E, Donnarumma M, Milani M, Fabbrocini G. Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study. G Ital Dermatol Venereol. 2020;155(5):676-679.
General Assembly of the World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14-18.
Dreno B, Poli F, Pawin H, et al. Development and evaluation of a global acne severity scale (GEA scale) suitable for France and Europe. J Eur Acad Dermatol Venereol. 2011;25(1):43-48.
Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dréno B. AFAST-adult female acne scoring tool: an easy-to-use tool for scoring acne in adult females. J Eur Acad Dermatol Venereol. 2016;30(5):824-828.
Poli F, Auffret N, Claudel JP, Leccia MT, Dreno B. AFAST: an adult female acne treatment algorithm for daily clinical practice. Eur J Dermatol. 2018;28(1):101-103.
Zaenglein AL. Acne vulgaris. N Engl J Med. 2018;379(14):1343-1352.
Holzmann R, Shakery K. Postadolescent acne in females. Skin Pharmacol Physiol. 2014;27(Suppl. 1):3-8.
Gollnick HPM. From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol. 2015;29:1-7.
Straight CE, Lee YH, Liu G, Kirby JS. Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings. J Am Acad Dermatol. 2015;72(5):822-827.
Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49(2):171-182.
Dreno B, Bagatin E, Blume-Peytavi U, Rocha M, Gollnick H. Female type of adult acne: physiological and psychological considerations and management. J Dtsch Dermatol Ges. 2018;16(10):1185-1194.
Williams C, Layton AM. Persistent acne in women. Am J Clin Dermatol. 2006;7(5):281-290.
De Lucas R, Moreno-Arias G, Perez-López M, Vera-Casaño Á, Aladren S, Milani M. Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients. BMC Dermatol. 2015;15(1):1-6.
Dupont E, Leveille C, Gomez J, Loigeret M, Loing E, Bilodeau D. Clinical efficacy of a serum integrating multiple cosmetic ingredients in the management of erythema of the face in aging skin. J Cosmet Dermatol. 2012;11(3):207-212.
Jang H, Matsuda A, Jung K, et al. Skin pH is the master switch of kallikrein 5-mediated skin barrier destruction in a murine atopic dermatitis model. J Invest Dermatol. 2016;136(1):127-135.
Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol. 2004;122(5):1235-1244.
Dréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;31:8-12.
Luebberding S, Krueger N, Kerscher M. Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH. Int J Cosmet Sci. 2013;35(5):477-483.
Schürer N. pH and acne. In: Surber C, Abels C, Maibach H, eds. pH of the skin: Issues and Challenges. Vol 54. Curr Probl Dermatol Basel; 2018:115-122.
Morita N, Arisawa M, Kondo Y, Takemoto T. Studies on constituents of iris genus plants. III. The constituents of Iris florentina L.(1). Chem Pharm Bull. 1973;21(3):600-603.
Suwattipanich, W. (2017). Efficacy of topical dipeptide diaminobutyroyl benzylamide diacetate 4% in neck wrinkle reduction (Doctoral dissertation, Mae Fah Luang University).
Stegemann A, Böhm M. Targeting the α7 nicotinic acetylcholine receptor-a novel road towards the future treatment of skin diseases. Exp Dermatol. 2020;29(9):924-931.
Yang YS, Lim HK, Hong KK, et al. Cigarette smoke-induced interleukin-1 alpha may be involved in the pathogenesis of adult acne. Ann Dermatol. 2014;26(1):11-16.
Rivera R, Guerra A. Management of acne in women over 25 years of age. Actas Dermosifiliogr. 2009;100(1):33-37.
Romańska-Gocka K, Woźniak M, Kaczmarek-Skamira E, Zegarska B. The possible role of diet in the pathogenesis of adult female acne. Postȩpy Dermatol Alergol. 2016;33(6):416-420.
Berra B, Rizzo AM. Glycemic index, glycemic load: new evidence for a link with acne. J Am Coll Nutr. 2009;28(sup4):450S-454S.
Reynolds RC, Lee S, Choi JY, et al. Effect of the glycemic index of carbohydrates on acne vulgaris. Nutrients. 2010;2(10):1060-1072.
Di Cerbo A, Laurino C, Palmieri B, Iannitti T. A dietary supplement improves facial photoaging and skin sebum, hydration and tonicity modulating serum fibronectin, neutrophil elastase 2, hyaluronic acid and carbonylated proteins. J Photochem Photobiol B Biol. 2015;144:94-103.
Walocko FM, Eber AE, Keri JE, Al-harbi MA, Nouri K. The role of nicotinamide in acne treatment. Dermatol Ther. 2017;30(5):e12481.
Cervantes J, Eber AE, Perper M, Nascimento VM, Nouri K, Keri JE. The role of zinc in the treatment of acne: a review of the literature. Dermatol Ther. 2018;31(1):e12576.
Mueller EA, Trapp S, Frentzel A, Kirch W, Brantl V. Efficacy and tolerability of oral lactoferrin supplementation in mild to moderate acne vulgaris: an exploratory study. Curr Med Res Opin. 2011;27(4):793-797.
Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Women's Dermatol. 2018;4(2):56-71.
Olutunmbi Y, Paley K, English JC III. Adolescent female acne: etiology and management. J Pediatr Adolesc Gynecol. 2008;21(4):171-176.